ASPEN PHARMACARE HOLDINGS LIMITED

(Incorporated in the Republic of South Africa) Registration number 1985/0002935/06

Share code: APN ISIN: ZAE000066692

("Aspen" or "the Company")

DEALING IN SECURITIES BY DIRECTORS, COMPANY SECRETARY AND DIRECTORS OF A MAJOR SUBSIDIARY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information:
DIRECTORS OF THE COMPANY
Director : Stephen Bradley Saad
Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 7 825
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R2 648 293
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Michael Guy Attridge
Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 6 468
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R2 189 029
Nature of interest : Direct beneficial
Clearance obtained : Yes
COMPANY SECRETARY OF THE COMPANY
Company Secretary : Riaan Verster
Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 1 211
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R409 850
Nature of interest : Direct beneficial
Clearance obtained : Yes
DIRECTORS OF A MAJOR SUBSIDIARY
Director : Sean Capazorio Subsidiary Company : Pharmacare Limited Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 3 042
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R1 029 534
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Morne Geyser Subsidiary Company : Pharmacare Limited Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive
bonus shares (vesting after three years)
Number of securities : 2 925
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R989 937
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Noel Guliwe Subsidiary Company : Pharmacare Limited Date of transaction : 20 October 2014
Nature of transaction : Acceptance of deferred incentive
bonus shares (vesting after three years)
Number of securities : 1 401
Class of securities : Ordinary shares
Grant price : R338.44
Value of Transaction : R474 154
Nature of interest : Direct beneficial
Clearance obtained : Yes
All acceptances of deferred bonus shares are deemed to be off-market trades.
Durban
23 October 2014
Sponsor
Investec Bank Limited

distributed by